Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Share-based Compensation (2016 - 2025)

CV Sciences (CVSI) has disclosed Share-based Compensation for 13 consecutive years, with $123000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 18.27% to $123000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $497000.0 through Dec 2025, up 92.64% year-over-year, with the annual reading at $497000.0 for FY2025, 92.64% up from the prior year.
  • Share-based Compensation hit $123000.0 in Q4 2025 for CV Sciences, down from $124000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $912000.0 in Q2 2021 to a low of $30000.0 in Q1 2024.
  • Historically, Share-based Compensation has averaged $259600.0 across 5 years, with a median of $123500.0 in 2025.
  • Biggest five-year swings in Share-based Compensation: tumbled 83.99% in 2022 and later surged 293.33% in 2025.
  • Year by year, Share-based Compensation stood at $835000.0 in 2021, then tumbled by 79.64% to $170000.0 in 2022, then plummeted by 80.59% to $33000.0 in 2023, then soared by 215.15% to $104000.0 in 2024, then rose by 18.27% to $123000.0 in 2025.
  • Business Quant data shows Share-based Compensation for CVSI at $123000.0 in Q4 2025, $124000.0 in Q3 2025, and $132000.0 in Q2 2025.